


Ask a doctor about a prescription for LEXXEMA 1 mg/ml CUTANEOUS SOLUTION
Package Leaflet: Information for the User
Lexxema 1mg/ml Cutaneous Solution
Methylprednisolone aceponate
Read this package leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the package leaflet:
Lexxema solution is an anti-inflammatory medicine (a corticosteroid) for exclusive cutaneous use on the scalp.
Lexxema solution inhibits inflammatory and allergic reactions of the skin, as well as those associated with an increase in the number of cells (hyperproliferation), leading to a reduction in redness and fluid accumulation (edema), and relieving itching, burning, or pain.
Lexxema solution is indicated for the treatment of inflammatory and pruriginous conditions of the scalp, such as:
Do not use Lexxema solution
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting to use Lexxema 1 mg/ml solution.
Use in children and adolescents
Lexxema solution should not be used in children under 18 years of age because there is no clinical experience available in this age group to date.
Use of Lexxema and other medicines
Tell your doctor, pharmacist, or nurse that you are using, have recently used, or might use any other medicine.
No interactions of Lexxema solution with other medicines are known.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
To avoid any risk to the child, do not use Lexxema solution if you are pregnant or breastfeeding, unless your doctor advises you to do so.
During breastfeeding, do not apply Lexxema solution to the areas that come into contact with the baby's skin.
Driving and using machines
Lexxema solution does not affect the ability to drive and use machines.
Follow the instructions for applying Lexxema solution exactly as indicated by your doctor. Consult your doctor or pharmacist if you have any doubts.
EXCLUSIVE CUTANEOUS USE ON THE SCALP.
The normal dose is:
Adults and adolescents over 18 years:
Lexxema solution is applied once a day to the affected areas of the scalp.
The solution should be applied in the form of drops with a gentle massage.
Your doctor will indicate the duration of treatment with Lexxema solution, but it should not exceed 4 weeks.
Use in children
Children under 18 years of age should not use Lexxema solution, as its safety in this age group has not been established.
If you use more Lexxema solution than you should
Studies have not indicated that any risk can be expected after the application of a single overdose. Repeated overdoses may produce side effects (see section 4).
After accidental oral ingestion of the solution, effects due to the excipient isopropyl alcohol may be expected. These effects may manifest as symptoms of central nervous system depression after ingestion of only a few milliliters or gastrointestinal alterations.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, or go to a medical center, or call the Toxicological Information Service, Telephone 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to use Lexxema solution
Do not apply a double dose to make up for forgotten doses. If you have forgotten a dose, continue with your usual schedule as instructed by your doctor or as described in this package leaflet.
If you stop using Lexxema solution
If you stop using Lexxema solution prematurely, the original symptoms of your skin problem may reappear. Please contact your doctor before stopping treatment with Lexxema solution.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
.
Like all medicines, Lexxema solution can cause side effects, although not everybody gets them.
The assessment of side effects is based on the following frequencies:
Very common: affects more than 1 in 10 patients
Common: affects 1 to 10 in 100 patients
Uncommon: affects 1 to 10 in 1,000 patients
Rare: affects 1 to 10 in 10,000 patients
Very rare: affects less than 1 in 10,000 patients.
Frequency not known (cannot be estimated from the available data).
Disorders of the skin and subcutaneous tissue
Uncommon: seborrheic dermatitis of the scalp and hair loss
Frequency not known: skin atrophy, acne, telangiectasias, skin striae, perioral dermatitis, skin discoloration, and allergic skin reactions
General disorders and administration site conditions
Common: burning sensation at the application site
Uncommon: pruritus, pain, dryness, folliculitis, irritation, and eczema at the application site, and localized sensation of heat.
Frequency not known: vesicles and erythema at the application site, hirsutism
Eyedisorders:
Frequency not known: blurred vision.
Side effects may occur not only in the treated area but also in completely different areas of the body. This happens if the active substance (a corticosteroid) passes into the body through the skin. This, for example, can increase the pressure in the eye (glaucoma).
Reporting of side effects
If you experience any of the side effects, talk to your doctor or pharmacist, even if it is a side effect not listed in this package leaflet. You can also report side effects directly through the Spanish Medicines Monitoring System, Website: www.notificaRAM.es.
By reporting side effects, you can help provide more information on the safety of this medicine.
.
Keep out of the sight and reach of children.
Do not store above 30°C.
Do not use Lexxema solution after the expiry date stated on the packaging after CAD. The expiry date is the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicine in the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
The active substance is Methylprednisolone aceponate. Each ml of solution contains 1 mg of methylprednisolone aceponate.
The other components (excipients) are: isopropyl myristate and isopropyl alcohol.
Appearance of the product and pack contents
Lexxema 1 mg/ml cutaneous solution is a clear, transparent liquid, presented in a multidose container with a dropper cap, with 50 ml and 20 ml.
Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing authorisation holder:
ITALFARMACO S.A.
C/ San Rafael, 3 – 28108 Alcobendas (Madrid)
Manufacturer:
Berlimed, S.A.
Polígono Industrial Santa Rosa
C/ Francisco Alonso, 7
28806 Alcalá de Henares (Madrid) - Spain
Date of the last revision of this package leaflet: October 2018
The average price of LEXXEMA 1 mg/ml CUTANEOUS SOLUTION in November, 2025 is around 8.71 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for LEXXEMA 1 mg/ml CUTANEOUS SOLUTION – subject to medical assessment and local rules.